3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Lymphoid
1
CNS
1
Conditions
Sleep Initiation and Maintenance Disorders
19
Breast Neoplasms
14
Neoplasms
12
Anxiety Disorders
7
Prostatic Neoplasms
6
Depression
5
Motor Activity
3
Lymphoma
3
Weight Loss
2
Pain
2
Overweight
2
Ovarian Neoplasms
2
Obesity
2
Multiple Myeloma
2
Lung Neoplasms
2
Glioblastoma
2
Fatigue
2
Colorectal Neoplasms
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Smoking Cessation
1
Smoking
1
Small Cell Lung Carcinoma
1
Sleep Wake Disorders
1
Sexual Dysfunctions, Psychological
1
Sexual Dysfunction, Physiological
1
Sedentary Behavior
1
Polycystic Ovary Syndrome
1
Pancreatic Neoplasms
1
Interventions
Temozolomide
94
Radiotherapy
59
Bevacizumab
59
Radiosurgery
41
Carboplatin
27
Irinotecan
26
Magnetic Resonance Spectroscopy
25
Surgical Procedures, Operative
23
Etoposide
22
Carmustine
20
Filgrastim
18
Erlotinib Hydrochloride
17
Cyclophosphamide
16
Cisplatin
16
Vincristine
15
Lomustine
15
Lapatinib
15
Sorafenib
13
Radiation
13
Trastuzumab
12
Nivolumab
12
Imatinib Mesylate
12
Thalidomide
11
Surveys and Questionnaires
11
Granulocyte Colony-Stimulating Factor
11
Radiotherapy, Intensity-Modulated
10
Aminolevulinic Acid
10
temsirolimus
9
Topotecan
9
Thiotepa
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Brain Neoplasms
×
Cognitive Behavioral Therapy
×
Clear all
NCT06439420
2025-10-01
CBT-I in PBT
Virginia Commonwealth University
Phase 2
Completed
70 enrolled